[go: up one dir, main page]

DK0553198T3 - Regulering af immunoglobulinproduktionen med interleukin-9 - Google Patents

Regulering af immunoglobulinproduktionen med interleukin-9

Info

Publication number
DK0553198T3
DK0553198T3 DK91918691T DK91918691T DK0553198T3 DK 0553198 T3 DK0553198 T3 DK 0553198T3 DK 91918691 T DK91918691 T DK 91918691T DK 91918691 T DK91918691 T DK 91918691T DK 0553198 T3 DK0553198 T3 DK 0553198T3
Authority
DK
Denmark
Prior art keywords
interleukin
production
regulation
immunoglobulin production
ige
Prior art date
Application number
DK91918691T
Other languages
Danish (da)
English (en)
Inventor
Jean-Michel Mencia-Huerta
Bernard Dugas
Catherine Druez
Pierre Braquet
Catherine Uyttenhove
Jean-Christophe Renauld
Snick Jacques Van
Original Assignee
Sod Conseils Rech Applic
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Ludwig Inst Cancer Res filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK0553198T3 publication Critical patent/DK0553198T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2033—IL-5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
DK91918691T 1990-10-05 1991-10-01 Regulering af immunoglobulinproduktionen med interleukin-9 DK0553198T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/593,238 US5132109A (en) 1990-10-05 1990-10-05 Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof
PCT/US1991/007208 WO1992005698A1 (fr) 1990-10-05 1991-10-01 Regulation de la production d'immunoglobine par l'interleukine-9

Publications (1)

Publication Number Publication Date
DK0553198T3 true DK0553198T3 (da) 1999-12-27

Family

ID=24373963

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98200841T DK0903150T3 (da) 1990-10-05 1991-10-01 Regulering af immunoglobulinproduktion med interleukin-9
DK91918691T DK0553198T3 (da) 1990-10-05 1991-10-01 Regulering af immunoglobulinproduktionen med interleukin-9

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK98200841T DK0903150T3 (da) 1990-10-05 1991-10-01 Regulering af immunoglobulinproduktion med interleukin-9

Country Status (11)

Country Link
US (1) US5132109A (fr)
EP (2) EP0553198B1 (fr)
JP (2) JP3205754B2 (fr)
AT (2) ATE234632T1 (fr)
AU (2) AU646509B2 (fr)
CA (1) CA2093434C (fr)
DE (2) DE69131450T2 (fr)
DK (2) DK0903150T3 (fr)
ES (2) ES2136065T3 (fr)
GR (1) GR3031518T3 (fr)
WO (1) WO1992005698A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE172470T1 (de) * 1992-03-09 1998-11-15 Ludwig Inst Cancer Res Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
DE4322330A1 (de) 1992-08-31 1994-03-03 Behringwerke Ag Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
US6911887B1 (en) 1994-09-12 2005-06-28 Matsushita Electric Industrial Co., Ltd. Inductor and method for producing the same
ZA967182B (en) * 1995-08-24 1998-05-25 Magainin Pharma Asthma associated factors as targets for treating atopic allergies including asthma and related disorders.
AU2007202406B2 (en) * 1995-08-24 2010-08-12 Ligand Pharmaceuticals Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
DK0846173T3 (da) * 1995-08-24 2006-01-16 Genaera Corp Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
US5830454A (en) * 1996-08-30 1998-11-03 Ludwig Institute For Cancer Research Method for treating cell mediated autoimmune disorders using interleukin-9
WO1998024904A2 (fr) * 1996-12-02 1998-06-11 Magainin Pharmaceuticals Inc. Variants de recepteur il-9, utilises pour le traitement et le diagnostic des allergies atopique, y compris l'asthme et les troubles apparentes
CA2689842A1 (fr) * 1996-12-02 1998-06-11 Genaera Corporation Variants de recepteur il-9, utilises pour le traitement et le diagnostic des allergies atopique, y compris l'asthme et les troubles apparentes
ATE540695T1 (de) * 2001-06-08 2012-01-15 Genaera Corp Verfahren zur modulation von il-13
JP4270974B2 (ja) 2003-08-04 2009-06-03 本田技研工業株式会社 車両における燃料タンクの配置構造
US20100219541A1 (en) 2007-09-28 2010-09-02 Konica Minolta Opto, Inc. Method for manufacturing optical device
CN101970220B (zh) 2008-03-19 2014-10-29 柯尼卡美能达精密光学株式会社 成型体及晶片透镜的制造方法
US20110012273A1 (en) 2008-03-19 2011-01-20 Akiko Hara Method for Producing Wafer Lens
JP4924777B2 (ja) 2010-04-27 2012-04-25 コニカミノルタオプト株式会社 撮像用レンズ、ウエハレンズ、ウエハレンズ積層体、撮像用レンズの製造方法、撮像用レンズの中間物、撮像用レンズの中間物の製造方法
US9828087B2 (en) * 2016-01-27 2017-11-28 Honeywell International Inc. Systems and methods for ground effect ceiling limit display

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US511951A (en) * 1894-01-02 Chusetts
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US5013824A (en) * 1985-11-19 1991-05-07 Schering Corporation Human interleukin-4 peptides and conjugates thereof
US4946945A (en) * 1987-06-23 1990-08-07 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
WO1991014767A1 (fr) * 1990-03-23 1991-10-03 Ludwig Institute For Cancer Research Procede de croissance et proliferation ameliorees de mastocytes

Also Published As

Publication number Publication date
ES2194273T3 (es) 2003-11-16
DE69131450T2 (de) 2000-03-30
ES2136065T3 (es) 1999-11-16
DE69133225T2 (de) 2004-02-19
EP0903150A1 (fr) 1999-03-24
EP0553198A1 (fr) 1993-08-04
EP0553198A4 (en) 1994-08-17
ATE234632T1 (de) 2003-04-15
US5132109A (en) 1992-07-21
DE69131450D1 (de) 1999-08-19
ATE182079T1 (de) 1999-07-15
EP0903150B1 (fr) 2003-03-19
JP3205754B2 (ja) 2001-09-04
DE69133225D1 (de) 2003-04-24
WO1992005698A1 (fr) 1992-04-16
CA2093434A1 (fr) 1992-04-06
DK0903150T3 (da) 2003-07-21
AU646509B2 (en) 1994-02-24
AU8760791A (en) 1992-04-28
GR3031518T3 (en) 2000-01-31
AU656493B2 (en) 1995-02-02
AU5243493A (en) 1994-02-17
JP2001253835A (ja) 2001-09-18
CA2093434C (fr) 1999-08-10
EP0553198B1 (fr) 1999-07-14
JPH06502404A (ja) 1994-03-17

Similar Documents

Publication Publication Date Title
DK0553198T3 (da) Regulering af immunoglobulinproduktionen med interleukin-9
DK0772396T3 (da) Fremgangsmåde til regulering af immunfunktion
DE69528888D1 (de) Regulierung von nf-kappa-b aktivität durch proteasome
PL313260A1 (en) Monoclonal antibodies having properties making them able to cause apoptosis
SE9102074D0 (sv) Tomour antigen specific antibody
BG37528A3 (bg) Метод за получаване на 4- аминофенил-амониев-тридецил- фосфонат
DK183590D0 (da) Fremgangsmaade til reduktion af immunoglobulin e-responser
FI935408A0 (fi) Spaoraemnesrikt tillsatsmedel, foerfarande foer framstaellning daerav, preparat innehaollande detta och dess anvaendning
FI850778A7 (fi) Menetelmä NO x-pitoisuuden alentamiseksi pyörrekerrospolttolaitteissa.
BG41993A3 (en) Means and method for increase in cold resistance of plant cultures
NO172596C (no) Apolipoprotein b-spesifikke monoklonale antistoffer produsert av to nye hybridomer, anvendelse av disse og diagnostiske systemer inneholdende disse
NL940019I1 (nl) Remming van het infecterende karakter in vitro en het cytopatische effect van htlv-iii/lav door 2',3'-didesoxycytidine
DK154188D0 (da) Kraftanlaeg med forbraending i fluidiseret leje
ES2164211T3 (es) Procedimiento mejorado para la fabricacion de sal de 5-(alcoximetil)piridin-2,3-dicarboxilato.
DK0479884T3 (da) Kraftværk med fluid-bed forbrændingsreaktor
BG35043A3 (en) Method for preparing condensed asymmetric triazine derivatives
DE3862547D1 (de) Vorrichtung zur anaeroben behandlung von biomasse.
DK364188A (da) Fremgangsmaade til fremstilling af kautsjukmkaatter med mindst et yderligere lag kautsjuk i randzonen
DK157276C (da) Fremgangsmaade og anlaeg til stroemforsyning af vekselstroemsnet med en dieselmotor
ES536028A0 (es) Un procedimiento para producir interferon inmune humano recombinante intacto
DE69124317D1 (de) Monoklonale Antikörper gegen Leptosphaeria
DK511479A (da) Regulering for koeremotor foedet af stroemretter i det svage feltomraade
GB8811342D0 (en) Expression of antibody heavy & light chain variable domains as active hetero-dimer in myeloma cells
DE69118827D1 (de) Antikörper gegen Hamsterimmunglobulinen
FI804079L (fi) Avdunstande luftfuktare foersedd med flaekt i